Thermal ablation plus toripalimab in patients with advanced hepatocellular carcinoma: Phase I results from a multicenter, open-label, controlled phase I/II trial (IR11330)

被引：5

作者：

Shi, L. ^{[1
]}

Zhou, C. ^{[1
]}

Long, X. ^{[2
]}

Li, H. ^{[1
]}

Chen, C. ^{[1
]}

Peng, C. ^{[1
]}

Li, P. ^{[3
]}

Li, J. ^{[4
]}

Gu, S. ^{[5
]}

Liang, B. ^{[6
]}

Liao, W. ^{[7
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Intervent Radiol Dept, Changsha, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Radiol Dept, Changsha, Peoples R China

[3] Hunan Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Radiol, Changsha, Peoples R China

[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China

[5] Hunan Canc Hosp, Dept Intervent Radiol, Changsha, Peoples R China

[6] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan, Peoples R China

[7] Cent South Univ, Xiangya Hosp, Dept Radiol, Changsha, Peoples R China

来源：

关键词：

D O I：

10.1016/j.annonc.2021.08.169

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

949P

引用

页码：S826 / S826

页数：1